Abstract
Broxaterol, a new inhaled beta-2 adrenergic agonist, showed efficacy and cardiovascular safety in a group of stable asthmatic subjects.
Original language | English |
---|---|
Title of host publication | Atti del XXIII Convegno della Societase europaea physiologiae clinicae respiratoriae Atene 20-24 giugno 1988 |
Pages | 9 |
Number of pages | 1 |
Publication status | Published - 1988 |
Keywords
- airway obstruction
- asthma
- broxaterol
- copd